The analysis presents long-term investment opportunities in three stocks. First, Colgate-Palmolive is identified as undervalued at $86 with a fair value of $148 based on the discounted cash flow valuation. It had a free cash flow of over 3.5 billion in 2024, its sales are considered stable as it is a consumers staples business. The second stock is MasterCard. With a target price of $540 and a current price of $597 the analysis says is overvalued. He forecasts over $491 billion and mentions that it is a hall of fame company, with economic advantages and an operating margin of around 60%. The last is CVS he indicates to buy and hold for the long term with a present free cash flow of over $4 billion in 2024, indicating that the price is well below the intrinsic value per share.